Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.
Press releases published on July 31, 2025

GSI Technology, Inc. Announces First Quarter Fiscal 2026 Results
SUNNYVALE, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (Nasdaq: GSIT) today reported financial results for its first fiscal quarter ended June 30, 2025. Summary Comments for First Quarter Fiscal Year 2026 SRAM revenue increased 7% …

Fidus Investment Corporation Schedules Second Quarter 2025 Earnings Release and Conference Call
EVANSTON, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ: FDUS) (“Fidus” or the “Company”) today announced that it will report its second quarter 2025 financial results on Thursday, August 7, 2025 after the close of the …

Rackspace Receives SBTi Approval for Net-Zero Targets, Reinforcing Commitment to Sustainable Operations and Innovation
SAN ANTONIO, July 31, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, announced today that the Science Based Targets Initiative (SBTi) has approved its near-term, long-term, and net- …

Sow Good to Hold Second Quarter 2025 Conference Call on Thursday, August 14, 2025, at 10:00 a.m. ET
IRVING, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Sow Good Inc. (Nasdaq: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, will hold a conference call on Thursday, August 14, 2025, at 10:00 a.m. Eastern time to …

Hydrofarm Holdings Group, Inc. to Announce Second Quarter 2025 Results on August 12, 2025
SHOEMAKERSVILLE, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled …

Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
Company expects to complete Phase 3 Aspire study in the second half of 2026 Aurora study of GTX-102 in additional ages and genotypes on track to initiate in the second half of 2025 NOVATO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical …

Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
RICHMOND, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company today announced that the company has scheduled the release of its second quarter 2025 financial results after the markets close on …

CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025
- Conference Call Scheduled for Thursday, August 14, 2025 at 4:30 pm ET - SARATOGA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial …

Pfeiffer Exhibits Vacuum and Abatement Solutions at SEMICON Taiwan
Pfeiffer Vacuum+Fab Solutions, a member of the Busch Group, announce its presence at SEMICON Taiwan 2025. ASSLAR, GERMANY, July 31, 2025 /EINPresswire.com/ -- The booth of Pfeiffer Vacuum+Fab Solutions will showcase the brand’s wide range of vacuum …

OrbimountAI Amplia la Cobertura de Senales Bursatiles Automatizadas en Intercambios Globales
RIGA, LATVIA, July 31, 2025 /EINPresswire.com/ -- OrbimountAI ha anunciado una ampliacion de su sistema automatizado de senales bursatiles, extendiendo su cobertura hacia una red mas amplia de intercambios internacionales. Este avance busca dar respuesta …

MulfinTradeAi startet fortschrittliche KI Aktien Signal Engine fuer globale Investoren
LONDON, UNITED KINGDOM, July 31, 2025 /EINPresswire.com/ -- MulfinTrade hat die Einfuehrung seiner neuen MulfinTradeAi Plattform bekanntgegeben, die eine KI basierte Signal Engine fuer den weltweiten Aktienhandel bereitstellt. Ziel ist es, durch praezise …

Fintrex Velocity Sets New Standard in High-Speed Financial Transactions
LONDON, UNITED KINGDOM, July 31, 2025 /EINPresswire.com/ -- In todays fast paced trading environment the ability to process and act on information with speed and precision has become a defining factor for market performance. Fintrex Velocity has …

Orchestra BioMed Announces Proposed Public Offering
NEW HOPE, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced …

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
• Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to invest $10 million in an equity private placement and an …

Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025
COPENHAGEN, Denmark, July 31, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter 2025 financial results and provide a business update on Thursday, August 7, 2025, after the close of the U.S. financial …

Asure Announces Second Quarter 2025 Results
Second Quarter 2025 Total Revenues Increased 7% to $30.1 million Recurring Revenues Grew 6% from Prior Year AUSTIN, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. (“we”, “us”, “our”, “Asure” or the “Company”) (Nasdaq: ASUR), a leading …

scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management …

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025
SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 7, 2025 at 4:30 pm ET …

Solésence Reports Second Quarter 2025 Financial Results
ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the second quarter ended June 30, …

National Healthcare Properties Announces Release Date for Second Quarter 2025 Results
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (“NHP”) announced today that it will release its financial results for the second quarter ended June 30, 2025 on Tuesday, August 5, 2025 after market …